SCHEMBL9116432

SCHEMBL9116432

Cc1ccc(C2=CC3(C=C2c2ccc(S(N)(=O)=O)cn2)CCC3)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.43
PTGS1 P23219 3/20 0.40
CA2 P00918 9/20 0.40
CA9 Q16790 8/20 0.40
CA1 P00915 7/20 0.40
CA5A P35218 5/20 0.40
CA5B Q9Y2D0 5/20 0.40
CA12 O43570 4/20 0.40
CA3 P07451 1/20 0.40
CA6 P23280 1/20 0.40
CA7 P43166 1/20 0.40
ALOX5AP P20292 1/20 0.36
CA4 P22748 4/20 0.36
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9239184 0.98 PTGS2 (0.43) PTGS2PTGS1CA2CA9CA1
SCHEMBL9117725 0.95 PTGS2 (0.45) PTGS2PTGS1CA2CA9CA1
SCHEMBL9117464 0.93 PTGS2 (0.51) PTGS2PTGS1CA2CA9CA1
SCHEMBL9117163 0.91 PTGS2 (0.51) PTGS2PTGS1CA2CA9CA1
SCHEMBL9117225 0.89 PTGS2 (0.50) PTGS2PTGS1ALOX5APKMT2ASMN1; SMN2
SCHEMBL9116501 0.88 PTGS2 (0.43) PTGS2PTGS1CA2CA9CA1
SCHEMBL9117334 0.88 PTGS2 (0.52) PTGS2PTGS1CA2CA9CA1
SCHEMBL9119256 0.88 CA2 (0.40) PTGS2PTGS1CA2CA9CA1
SCHEMBL9118062 0.88 PTGS2 (0.53) PTGS2PTGS1CA2CA9CA1
SCHEMBL9117275 0.87 PTGS2 (0.38) PTGS2PTGS1CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed